Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

How to Estimate Disease Burden in PsA

  |  

The use of objective, validated outcome measures to track progress in symptom control for patients with psoriatic arthritis has emerged as a way to optimize outcomes for patients with psoriatic arthritis. Various tools are available: the Psoriasis Area and Severity Index (PASI), the ACR20/50/70, the Leeds Enthesitis Index (LEI) and more. To learn more, read the full article from The Rheumatologist, October 2021: "Minimizing Disease Activity in Psoriatic Arthritis."

A single domain measure will accurately reflect the overall disease burden of PsA in a given patient.